This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 03/28/2020
Location: Teleconference
Subject: Lessons from the Front Lines: COVID-19
FDA Participant/Group: DAYLE CRISTINZIO; ANAND SHAH; DEBRA BIRNKRANT; JEFFREY MURRAY;
Non FDA Participant/Group: Industry, government, and academia

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 03/24/2020
Location: Virtual
Subject: The Role of Digital Health Technologies in Drug Development - Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Academics, industry, government, and other stakeholders

Event Date: 03/24/2020
Location: Virtual
Subject: Wall Street Journal Annual Health Forum - Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Media, academics, industry, patients, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event